Cargando…
Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABA(A) receptor expression and CREB1 activity in rats
Aripiprazole is a D(2)-like receptor (D(2)R) partial agonist with a favourable clinical profile. Previous investigations indicated that acute and short-term administration of aripiprazole had effects on PKA activity, GSK3β-dependent pathways, GABA(A) receptors, NMDA receptor and CREB1 in the brain....
Autores principales: | Pan, Bo, Huang, Xu-Feng, Deng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951756/ https://www.ncbi.nlm.nih.gov/pubmed/27435909 http://dx.doi.org/10.1038/srep30040 |
Ejemplares similares
-
PM439. Chronic effects of aripiprazole on the GSK3ß-dependent pathways, NMDA receptor and CREB1 in the rat brain
por: Pan, Bo, et al.
Publicado: (2016) -
Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats
por: Pan, Bo, et al.
Publicado: (2016) -
Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats
por: Pan, Bo, et al.
Publicado: (2015) -
Neuroprotection by aripiprazole against β-amyloid-induced toxicity by P-CK2α activation via inhibition of GSK-3β
por: Park, So Youn, et al.
Publicado: (2017) -
Effects of Risperidone and Prenatal Poly I:C Exposure on GABA(A) Receptors and AKT-GSK3β Pathway in the Ventral Tegmental Area of Female Juvenile Rats
por: Chen, Shiyan, et al.
Publicado: (2022)